Notice of Cipher Pharmaceuticals Inc. Q2 2013 Conference Call

About this update from Cipher Pharmaceuticals Inc.

[{"type":"text","content":"\n\n\nToronto Stock Exchange Symbol: DND\n\n\nMISSISSAUGA, ON, July 17, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), today announced it\n will host a conference call for its Q2 2013 financial results on\n Wednesday, July 31, 2013.\n\n\nQ2 2013 CONFERENCE CALL\n\n\nWHEN: Wednesday, July 31, 2013 at 8:30AM ET\n\n\nCONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450\n or 1-888-231-8191. A live audio webcast will be available through http://www.cipherpharma.com or http://bit.ly/15IeDer. An archived replay of the webcast will be available for 365 days.\n\n\nAbout Cipher Pharmaceuticals Inc.\n\n\nCipher Pharmaceuticals (TSX: DND; OTC: CPHMF) is a growing specialty\n pharmaceutical company with three commercial products and a fourth in\n development. Our product candidates are typically improved formulations\n of successful, currently marketed drugs. We in-license a product,\n manage the required clinical development and regulatory approval\n process, and either out-license it to a marketing partner, or, in\n Canada, we may market the product ourselves. Our core capabilities are\n in clinical and regulatory affairs, product licensing, supply chain\n management, and marketing and sales. Since the Company was founded in\n 2000, we have achieved final regulatory approval in the U.S. and Canada\n for all three of our original products and completed six marketing\n partnerships, generating growing licensing revenue.\n\n\nFor more information, please visit www.cipherpharma.com.\n\nSOURCE: Cipher Pharmaceuticals Inc.\n\n\n Craig Armitage Investor Relations TMX Equicom (416) 815-0700 ext 278 (416) 815-0080 [email protected] Larry Andrews President and CEO Cipher Pharmaceuticals (905) 602-5840 ext 324 (905) 602-0628 [email protected] Copyright CNW Group 2013","length":2787,"tagName":"div"}]

More updates from Cipher Pharmaceuticals Inc.